When cancer cells are physically squeezed, they mount an instant, high-energy defense by rushing mitochondria to the cell ...

Triple negative breast cancer (TNBC) is one of the most aggressive and hardest forms of breast cancer to treat, but a new study led by Weill Cornell Medicine suggests a surprising way to stop it from ...

Hodgkin lymphoma and other malignancies that express the CD30 protein have been the scourge of oncologists for decades. For ...

T cell therapy, which uses a patient's own immune cells to fight cancer, has emerged as a powerful way to treat lymphoma and ...

Cancer cells transfer mitochondria through nanotubes to healthy neighboring cells, turning them into tumor-supporting accomplices, a new study shows.

Japanese scientists successfully eliminated cancer tumors using live bacteria, a new therapy that acts independently of the ...

A protein notorious for its role in Alzheimer’s disease may hold the key to supercharging the aging immune system, according ...

Circulating tumor cells allow researchers to detect cancer early, provide an accurate prognosis, monitor progression, and ...

In experiments with mouse models of breast, pancreatic, and muscle cancers, researchers at Johns Hopkins All Children’s ...

PHILADELPHIA — Penn researchers have found that a combination of common, generic drugs could be used to kill dormant breast cancer cells, preventing the disease from recurring. Though often highly ...

The U.S. Food and Drug Administration (FDA) has granted priority review and breakthrough therapy designation to the ...

HPV, a very common virus, is found to hijack the body's cells to directly drive skin cancer growth, even after surgeries and ...